AI-Enhanced Molecular Modeling Shortens Path to Market of New Drugs
AI-Enhanced Molecular Modeling Shortens Path to Market of New Drugs
Biosimulytics focuses on developing a platform that enables
biopharma companies to shorten the time to market of new drug compounds by simulating lead optimization, one of the most challenging steps of the drug development process. This process
relies on tedious laboratory experiments to crystallize ...